6533b826fe1ef96bd1285148
RESEARCH PRODUCT
Efficacy of 1-week ranitidine-bismuth-citrate (RBC)-based triple therapy for eradication of Helicobacter pylori infection
Sergio VigneriVincenzo Savarinosubject
medicine.medical_specialtyHelicobacter pylori infectionRanitidineGastroenterologyHelicobacter InfectionsRanitidineMetronidazoleInternal medicineOrganometallic CompoundsmedicineHumansPharmacology (medical)Clinical Trials as TopicHelicobacter pyloriHepatologybiologybusiness.industryAnti-ulcer AgentGastroenterologyHelicobacter pyloriAnti-Ulcer AgentsHelicobacter Infectionsbiology.organism_classificationAnti-Bacterial AgentsMetronidazoleRanitidine HydrochlorideDrug Therapy CombinationAntacidsbusinessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
1999-09-01 | Alimentary Pharmacology & Therapeutics |